Celecoxib may prevent lung cancer in former smokers
Wednesday, July 6, 2011 - 15:32
in Health & Medicine
Celecoxib may emerge as a potent chemopreventive agent for lung cancer, according to a recent study. Researchers tested celecoxib, a COX-2 inhibitor, among patients who were former smokers and found a significant benefit in bronchial health as measured by the Ki-67 labeling index, a marker of cellular proliferation or growth, as well as a number of other biomarkers. The findings follow a previous report that showed a similar effect on Ki-67 among former smokers and current smokers.